Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,276,762 papers from all fields of science
Search
Sign In
Create Free Account
oxymorphone-3-glucuronide
Known as:
OXM-3-G
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Glucuronides
Oxymorphone
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Detection and quantification of codeine-6-glucuronide, hydromorphone-3-glucuronide, oxymorphone-3-glucuronide, morphine 3-glucuronide and morphine-6-glucuronide in human hair from opioid users by LC…
Megan Grabenauer
,
Nichole Bynum
,
+4 authors
R. Flegel
Journal of Analytical Toxicology
2018
Corpus ID: 3807993
Current hair testing methods that rely solely on quantification of parent drug compounds are unable to definitively distinguish…
Expand
2012
2012
An open-label pharmacokinetic study of oxymorphone extended release in the presence of naltrexone in the older adult.
J. Pergolizzi
,
R. Raffa
,
+4 authors
E. Gould
Journal of Opioid Management
2012
Corpus ID: 32426881
OBJECTIVE The aging population generally has greater need for analgesics and is best served by having as many good therapeutic…
Expand
2012
2012
Simultaneous determination of oxymorphone and its active metabolite 6-OH-oxymorphone in human plasma by high performance liquid chromatography-tandem mass spectrometry.
Wuyi Zha
,
L. Shum
Journal of chromatography. B, Analytical…
2012
Corpus ID: 24317312
Review
2007
Review
2007
Use of oral oxymorphone in the elderly.
D. Guay
The Consultant pharmacist : the journal of the…
2007
Corpus ID: 25191084
OBJECTIVE To review the pharmacodynamics, pharmacokinetics, efficacy, tolerability, dosing, and role of oral oxymorphone…
Expand
Highly Cited
2004
Highly Cited
2004
Pharmacokinetics and Dose‐Proportionality of Oxymorphone Extended Release and Its Metabolites: Results of a Randomized Crossover Study
M. Adams
,
H. Ahdieh
Pharmacotherapy
2004
Corpus ID: 45347681
Study Objective. To evaluate the pharmacokinetics and dose‐proportionality of four dose strengths (5, 10, 20, and 40 mg) of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required